Page last updated: 2024-08-25

rosiglitazone and Lymphoma, T-Cell

rosiglitazone has been researched along with Lymphoma, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chadburn, A; Csernus, B; Hyjek, E; Jo, SH; Liu, Y; Wang, YL; Yang, C	1

Other Studies

1 other study(ies) available for rosiglitazone and Lymphoma, T-Cell

Article	Year
Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism. The American journal of pathology, 2007, Volume: 170, Issue:2 Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Fatty Acids; Glucose; Humans; Hypoglycemic Agents; Ligands; Lymphoma, T-Cell; Membrane Potential, Mitochondrial; Mitochondria; Neoplasm Proteins; Peroxisome Proliferators; PPAR gamma; Prostaglandin D2; Pyrimidines; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones	2007

Article

Year

Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.

The American journal of pathology, 2007, Volume: 170, Issue:2

Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Fatty Acids; Glucose; Humans; Hypoglycemic Agents; Ligands; Lymphoma, T-Cell; Membrane Potential, Mitochondrial; Mitochondria; Neoplasm Proteins; Peroxisome Proliferators; PPAR gamma; Prostaglandin D2; Pyrimidines; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones

2007